Healthcare Services

Near-Patient Molecular Solutions Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Near-Patient Molecular Solutions Market In 2026 And What Value Is Projected For 2030?

The near-patient molecular solutions market has exhibited significant expansion in recent years. This market is expected to reach $4.99 billion in 2026 from $4.54 billion in 2025, progressing at a compound annual growth rate (CAGR) of 9.8%. Factors contributing to the historical growth include the broader application of molecular diagnostic techniques, the necessity for quick test result delivery, the shift towards decentralized laboratory services, an increase in outpatient diagnostic environments, and the adoption of portable diagnostic instruments.

The near-patient molecular solutions market is anticipated to experience substantial expansion in the coming years. It is projected to reach $7.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.5%. This growth in the forecast period is primarily driven by an increased focus on personalized medicine, a rising demand for home and remote testing solutions, technological advancements in miniaturized molecular platforms, the expansion of infectious disease surveillance, and better integration with digital health ecosystems. Significant trends during this period include a greater adoption of point-of-care molecular testing devices, an escalating need for rapid infectious disease diagnostics, the growing integration of portable PCR platforms, the expansion of decentralized diagnostic infrastructure, and an enhanced focus on near-patient testing accuracy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30333&type=smp

What Major Drivers Are Influencing Demand In The Near-Patient Molecular Solutions Market?

The increasing need for home-based point-of-care devices is anticipated to propel the expansion of the near patient molecular solutions market in the coming years. These home-based point-of-care devices are diagnostic testing systems that allow patients or non-laboratory users to operate them at or near their homes, facilitating sample collection, analysis, or result reading outside a conventional central laboratory setting and close to the point of care. The rising demand for these devices is primarily driven by a growing consumer preference for convenient, rapid, and accessible health monitoring solutions outside traditional healthcare environments. Near-patient molecular solutions enhance home-based point-of-care devices by providing accurate, rapid, and portable molecular diagnostics that can be reliably utilized beyond conventional laboratory settings. For instance, in February 2023, the US Food & Drug Administration (FDA), a US-based government agency, reported in its 2023 COVID-19 testing update that there was one Emergency Use Authorization (EUA) for a molecular prescription at-home test, two EUAs for antigen prescription at-home tests, 26 EUAs for antigen over-the-counter (OTC) at-home tests, and four EUAs for molecular OTC at-home tests. Hence, the increasing demand for home-based point-of-care devices is fueling the growth of the near-patient molecular solutions market.

What Are The Key Segments Of The Near-Patient Molecular Solutions Market?

The near-patient molecular solutions market covered in this report is segmented –

1) By Product Type: Infectious Diseases Testing Kits, Urinalysis Testing Kits, Tumor Or Cancer Markers, Pregnancy And Fertility, Hematology Testing Kits, Glucose Monitoring Kits, Drugs-Of-Abuse Testing Kits, Coagulation Monitoring Kits, Cardiometabolic Monitoring Kits, Other Product Types

2) By Technology: Polymerase Chain Reaction (PCR)-Based, Genetic Sequencing-Based, Hybridization-Based, Microarray-Based

3) By End-User: Hospitals And Clinics, Ambulatory Care Centers, Research Laboratories, Home Care Settings, Other End-Users

Subsegments:

1) By Infectious Diseases Testing Kits: Hepatitis Testing Kits, Human Immunodeficiency Virus Testing Kits, Influenza Testing Kits, COVID-19 Testing Kits

2) By Urinalysis Testing Kits: Protein Testing Kits, Glucose Testing Kits, Ketone Testing Kits, Nitrite Testing Kits

3) By Tumor Or Cancer Markers: Prostate-Specific Antigen Testing Kits, Carcinoembryonic Antigen Testing Kits, Cancer Antigen 125 Testing Kits, Alpha-Fetoprotein Testing Kits

4) By Pregnancy And Fertility: Ovulation Testing Kits, Early Pregnancy Testing Kits, Digital Pregnancy Testing Kits, Home Fertility Monitoring Kits

5) By Hematology Testing Kits: Complete Blood Count Testing Kits, Hemoglobin Testing Kits, White Blood Cell Count Testing Kits, Platelet Count Testing Kits

6) By Glucose Monitoring Kits: Self-Monitoring Blood Glucose Kits, Continuous Glucose Monitoring Kits, Non-Invasive Glucose Testing Kits, Disposable Glucose Test Strips

7) By Drugs-Of-Abuse Testing Kits: Urine Drug Testing Kits, Saliva Drug Testing Kits, Hair Drug Testing Kits, Blood Drug Testing Kits

8) By Coagulation Monitoring Kits: Prothrombin Time Testing Kits, International Normalized Ratio Testing Kits, Activated Partial Thromboplastin Time Testing Kits, D-Dimer Testing Kits

9) By Cardiometabolic Monitoring Kits: Cholesterol Testing Kits, Triglyceride Testing Kits, Low-Density Lipoprotein Testing Kits, High-Density Lipoprotein Testing Kits

10) By Other Product Types: Allergy Testing Kits, Thyroid Function Testing Kits, Vitamin Deficiency Testing Kits, Liver Function Testing Kits

How Are Trends Transforming The Near-Patient Molecular Solutions Market Landscape?

Leading companies in the near-patient molecular solutions market are concentrating on integrating technological advancements, such as isothermal nucleic acid amplification, to improve testing efficiency, portability, and diagnostic accuracy. This sophisticated molecular diagnostic method amplifies target nucleic acid sequences at a constant temperature, removing the need for thermal cycling typically found in conventional polymerase chain reaction (PCR), thus enabling quick, sensitive, and compact molecular testing. As an example, in June 2023, Cue Health Inc., a US-based healthcare technology company focused on molecular diagnostics, secured FDA marketing authorization for the Cue COVID-19 Molecular Test. This device, based on isothermal amplification, is designed for the detection of SARS-CoV-2 RNA at home and at the point of care. The system includes a single-use cartridge, a Bluetooth-enabled reader, and a mobile app interface that walks users through the test and delivers molecular results in about 20 minutes. The Cue COVID-19 molecular test boosts access to accurate molecular-level diagnostics, cuts down turnaround time, and supports real-time health decision-making outside traditional laboratory environments.

Who Are The Leading Companies Operating In The Near-Patient Molecular Solutions Market?

Major companies operating in the near-patient molecular solutions market are Bosch Healthcare Solutions GmbH, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Hologic Inc., bioMérieux SA, Sysmex Corporation, QuidelOrtho Corporation, QIAGEN NV, DiaSorin SpA, OraSure Technologies Inc., Molbio Diagnostics Pvt Ltd, Cue Health Inc., Biocartis Group NV, Vela Diagnostics Pte Ltd, Co-Diagnostics Inc., Hyris Ltd, Genedrive plc.

Read the full near-patient molecular solutions market report here:

https://www.thebusinessresearchcompany.com/report/global-near-patient-molecular-solutions-market-report

Which Region Shows The Strongest Potential For Future Growth In The Near-Patient Molecular Solutions Market?

North America was the largest region in the near-patient molecular solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the near-patient molecular solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Near-Patient Molecular Solutions Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30333&type=smp

Browse Through More Reports Similar to the Global Near-Patient Molecular Solutions Market 2026, By The Business Research Company

Household Insecticides Global Market Report

https://www.thebusinessresearchcompany.com/report/household-insecticides-global-market-report

Edible Insects Global Market Report

https://www.thebusinessresearchcompany.com/report/edible-insects-global-market-report

Tick Repellent Global Market Report

https://www.thebusinessresearchcompany.com/report/tick-repellent-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795